Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models
Margaret J. de Villiers(Imperial College London), Devin Razavi‐Shearer(University of Health Sciences Antigua), Ivane Gamkrelidze, Shevanthi Nayagam(Imperial College London), Timothy B. Hallett(Imperial College London), Homie Razavi(Center for Disease Analysis)
Cited by 11
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
|PLoS Medicine|2012|406
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
|The Lancet. Gastroenterology & hepatology|2023|399